These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 19047607)
21. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia. Kupferminc M; Rimon E; Many A; Maslovitz S; Lessing JB; Gamzu R Blood Coagul Fibrinolysis; 2011 Mar; 22(2):123-6. PubMed ID: 21192252 [TBL] [Abstract][Full Text] [Related]
22. Folic acid sensitive birth defects in association with intrauterine exposure to folic acid antagonists. Meijer WM; de Walle HE; Kerstjens-Frederikse WS; de Jong-van den Berg LT Reprod Toxicol; 2005; 20(2):203-7. PubMed ID: 15907654 [TBL] [Abstract][Full Text] [Related]
23. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. Salafia CM; Minior VK; Pezzullo JC; Popek EJ; Rosenkrantz TS; Vintzileos AM Am J Obstet Gynecol; 1995 Oct; 173(4):1049-57. PubMed ID: 7485292 [TBL] [Abstract][Full Text] [Related]
24. Are maternal and neonatal outcomes different in placental abruption between women with and without preeclampsia? Han M; Liu D; Zeb S; Li C; Tong M; Li X; Chen Q Placenta; 2019 Sep; 85():69-73. PubMed ID: 31311680 [TBL] [Abstract][Full Text] [Related]
25. Placenta-mediated pregnancy complications are not associated with fetal or paternal factor V Leiden mutation. Nevalainen J; Ignatius J; Savolainen ER; Ryynanen M; Jarvenpaa J Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():32-35. PubMed ID: 30243226 [TBL] [Abstract][Full Text] [Related]
26. Brief Report: Association Between Pregnancy Outcomes and Death From Cardiovascular Causes in Parous Women With Systemic Lupus Erythematosus: A Study Using Swedish Population Registries. Soh MC; Nelson-Piercy C; Dib F; Westgren M; McCowan L; Pasupathy D Arthritis Rheumatol; 2015 Sep; 67(9):2376-82. PubMed ID: 26016688 [TBL] [Abstract][Full Text] [Related]
27. Placental abruption and placental weight - implications for fetal growth. Ananth CV; Williams MA Acta Obstet Gynecol Scand; 2013 Oct; 92(10):1143-50. PubMed ID: 23750805 [TBL] [Abstract][Full Text] [Related]
28. Folic acid antagonist use before and during pregnancy and risk for selected birth defects. Kerr SM; Parker SE; Mitchell AA; Tinker SC; Werler MM Birth Defects Res; 2020 Nov; 112(18):1526-1540. PubMed ID: 32875745 [TBL] [Abstract][Full Text] [Related]
29. Neural tube defects in relation to use of folic acid antagonists during pregnancy. Hernández-Díaz S; Werler MM; Walker AM; Mitchell AA Am J Epidemiol; 2001 May; 153(10):961-8. PubMed ID: 11384952 [TBL] [Abstract][Full Text] [Related]
30. Metabolic syndrome and the risk of placental dysfunction. Ray JG; Vermeulen MJ; Schull MJ; McDonald S; Redelmeier DA J Obstet Gynaecol Can; 2005 Dec; 27(12):1095-101. PubMed ID: 16524527 [TBL] [Abstract][Full Text] [Related]
31. Association of Shorter Height with Increased Risk of Ischaemic Placental Disease. Ogawa K; Morisaki N; Saito S; Sato S; Fujiwara T; Sago H Paediatr Perinat Epidemiol; 2017 May; 31(3):198-205. PubMed ID: 28317131 [TBL] [Abstract][Full Text] [Related]
32. Effect of interpregnancy interval after a first pregnancy complicated by placental abruption, on adverse maternal and fetal outcomes in a second pregnancy. Rohde RL; Luong L; Adjei Boakye E; Chang JJ J Matern Fetal Neonatal Med; 2020 Nov; 33(22):3809-3815. PubMed ID: 30810416 [No Abstract] [Full Text] [Related]
34. Associations between in utero exposure to polybrominated diphenyl ethers, pathophysiological state of fetal growth and placental DNA methylation changes. Zhao Y; Song Q; Ge W; Jin Y; Chen S; Zhao Y; Xiao X; Zhang Y Environ Int; 2019 Dec; 133(Pt B):105255. PubMed ID: 31655276 [TBL] [Abstract][Full Text] [Related]